Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Granules

Approval Number

国药准字H20243981

Company浙江恒研医药科技有限公司

Registration Date

June 11, 2024

Drug Information

Generic Name

利伐沙班颗粒

Dosage Form

颗粒剂

Strength

10mg

Drug Type

化学药品

Registration Date

June 11, 2024

Company Information

Applicant Company

Company Name浙江恒研医药科技有限公司

Company Address

浙江省金华市东阳市江北街道猴塘社区广福东街23号总部中心C幢西楼0802-1室

Manufacturing Company

Company Name浙江赛默制药有限公司

Company Address

浙江省金华市婺城区汤溪镇永湖街788号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利伐沙班颗粒 - NMPA 批准文号 | MedPath